3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Weight Loss
2
Stomach Neoplasms
2
Malnutrition
2
Esophageal Neoplasms
2
Pituitary Neoplasms
1
Periampullary Tumors
1
Pancreatic Neuroendocrine Tumor G2
1
Pancreatic Neoplasms
1
Lymphocele
1
Endocrine System Diseases
1
Duodenal Neoplasms
1
Breast Neoplasms
1
Acromegaly
1
Interventions
Proton Therapy
2
Propofol
2
Hydrocortisone
2
Desflurane
2
parecoxib
1
loxoprofen
1
Yoga
1
Transcranial Magnetic Stimulation
1
Tramadol
1
Surgical Procedures, Operative
1
Supine Position
1
Sevoflurane
1
Saline Solution
1
Rosiglitazone
1
Resistance Training
1
Radiation Dose Hypofractionation
1
Protons
1
Positron-Emission Tomography
1
Octreotide
1
Neurosurgical Procedures
1
Neuropsychological Tests
1
Nasal Lavage
1
Human Growth Hormone
1
Endoscopic Mucosal Resection
1
Early Intervention, Educational
1
Dexamethasone
1
Deamino Arginine Vasopressin
1
Cabergoline
1
Bromocriptine
1
Bed Rest
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pituitary Neoplasms
×
Octreotide
×
Clear all
NCT01029275
2014-07-31
SAPORO
University Hospital, Rouen
Phase NA
Completed
89 enrolled